# FDA Inspection 1306964 - Quagen Pharma, LLC - April 17, 2026

Source: https://www.keypedia.com/records/fda_inspections/quagen-pharma-llc/a4caf3ca-2565-4fcf-b66a-61e7e92df275
Source feed: FDA_Inspections

> FDA Inspection 1306964 for Quagen Pharma, LLC on April 17, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1306964
- Company Name: Quagen Pharma, LLC
- Inspection Date: 2026-04-17
- Product Type: Human Drugs
- Office Name: New Jersey District Office

## Related Documents

- [FDA Inspection 1207909 - 2023-05-09](https://www.keypedia.com/records/fda_inspections/quagen-pharma-llc/666fc434-9541-4099-b5b5-1371247a8209)
- [FDA Inspection 1131910 - 2020-10-26](https://www.keypedia.com/records/fda_inspections/quagen-pharma-llc/37c76534-357b-4c19-a023-7470a89d61f6)

Company: https://www.keypedia.com/companies/quagen-pharma-llc/cd9437ab-54e0-430e-a568-3835f717bdf1

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248